Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (CrossMab)
TypeName: Business Offer
Category:
Offer Date:2019/07/07
Country: United States
Summary: Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget NK cells to genus plasmodium. It is designed for the research of Malaria therapy.https://www.creative-biolabs.com/bsab/symbolsearch-cd89%2520%2526%2520malaria%2520antigen.htm
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
